Sign in
Back
Verteporfin in Photodynamic Therapy: report no. 5
Journal article   Peer reviewed

Verteporfin in Photodynamic Therapy: report no. 5

Francesco Bandello, Kevin Blinder, Neil M Bressler, Alison L Brown, Joan W Miller, Michael J Potter, Constantin Pournaras, Al Reaves, Philip J Rosenfeld, Jason S Slakter, …
Ophthalmology (Rochester, Minn.), Vol.111(11), pp.2144-2144
2004-11
DOI: https://doi.org/10.1016/j.ophtha.2004.08.002
PMID: 15522385

Abstract

Myopia - complications Porphyrins - therapeutic use Choroidal Neovascularization - drug therapy Photosensitizing Agents - therapeutic use Fovea Centralis Humans Choroidal Neovascularization - etiology Photochemotherapy Visual Acuity - physiology Randomized Controlled Trials as Topic

Metrics

16 Record Views
5 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.36 Ophthalmology
1.36.383 Diabetic Retinopathy
Web Of Science research areas
Ophthalmology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details